CompletedNCT06567587
Dexmedetomidine for agitation in people with psychosis and COPD
About this title
Read the official source — NCT06567587Observational studyAges 18–60EgyptSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- TantaSee all locations and recruitment
Study information
Study start dateStarted: June 10, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 70
- Sponsor
- Tanta University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Device, Drug
- Locations
- Egypt
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06567587
- Official title
Show the full official title
Assessing the Efficacy of Dexmedetomidine in Alleviating Agitation for Exacerbated COPD Patients Who Are Treated for Psychosis Requiring Non- Invasive Ventilation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tanta University, a university.
Did this study involve medication?
Yes. The study involved medication, including Dexmedetomidine.
Who was this study for?
Listed age limits: 18 years to 60 years.
